The key cellular senescence related molecule RRM2 regulates prostate cancer progression and resistance to docetaxel treatment - Cheng, Bisheng; Li, Lingfeng; Wu, Yongxin; Luo, Tianlong; Tang, Chen; Wang, Qiong; Zhou, Qianghua; Wu, Jilin; Lai, Yiming; Zhu, Dingjun; Du, Tao; Huang, Hai (Cell & bioscience, 2023)
Keywords: 1-Phosphatidylinositol 3-kinase; AKT protein; Analysis; Annexins; Apoptosis; Cancer; Cancer therapies; Castration; Cell culture; Cell growth; Chemotherapy; Development and progression; Docetaxel; Drug resistance; Gene expression; Genetic aspects; Health aspects; Medical prognosis; Oncology; Overexpression; Plasmids; Prostate cancer; Ribonucleotide reductase; RRM2; Senescence; Survival analysis; Tumor cell lines; Tumors; Xenografts; United States--US; California; Oncology; Chemotherapy; RRM2; Prostate cancer; Docetaxel